ESC Premium Access

Drug - Eluting stent

Event: ESC CONGRESS 2016
Topic: PCI / stents: devices and technique
Session type: Advances in Science
Date: 27 August 2016
Time: 13:30 - 15:00

Session

5 presentations in this session

State of the art in drug eluting stent technology.

Speaker: Professor R. Byrne (Dublin, IE)
Thumbnail

Ten year clinical outcome of a large registry with unrestricted use of DES

Speaker: Professor R. van Geuns (Nijmegen, NL)
Thumbnail

Long-term risk of stent thrombosis and restenosis after treatment with drug-eluting stents: A report from SCAAR

Speaker: Professor E. Omerovic (Gothenburg, SE)
Thumbnail

Long-term clinical outcomes of biolimus-eluting stents with biodegradable versus bare-metal stents in patients with acute STEMI: 5 Year results of the randomized COMFORTABLE AMI trial.

Speaker: Doctor L. Raber (Bern, CH)
Thumbnail

Future direction for research in drug - eluting stent technology.

Speaker: Doctor M. Morice (Massy, FR)
Thumbnail

5 speakers from this session

Professor Robert Byrne

Mater Private Hospital, Dublin (Ireland)
14 presentations
1 follower

Professor Robert-Jan Matthijs van Geuns

Radboud University Medical Centre, Nijmegen (Netherlands (The))
0 follower

Professor Elmir Omerovic

Sahlgrenska University Hospital, Gothenburg (Sweden)
10 presentations
0 follower

Doctor Lorenz Raber

Bern University Hospital, Department of Cardiology, Bern (Switzerland)
8 presentations
0 follower

Doctor Marie-Claude Morice

Institut Hospitalier Jacques Cartier, ICPS, Massy (France)
7 presentations
0 follower

This platform is supported by

logo Novo Nordisk